Molecular mechanisms of coronary collateral vessel growth

Circulation Research

Volumn 79, Issue 5, 1996, Pages 911-919

  Schaper, Wolfgang ^a   Ito, Wulf D ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

angiogenesis; collateral arteries; heart

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN B; VASCULOTROPIN;

ANGIOGENESIS; CELL PROLIFERATION; COLLATERAL CIRCULATION; CORONARY ARTERY OBSTRUCTION; GROWTH REGULATION; HEART MUSCLE ISCHEMIA; HUMAN; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; SHORT SURVEY; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

EID: 0029974130     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.79.5.911     Document Type: Short Survey

References (111)

1. Fulton WFM. The Coronary Arteries. Springfield, Ill: Charles C Thomas Publishers; 1965.
2. Spalteholz W. Die Koronararterien des Herzens. Verhandl Anat Ges. 1907;21:141; in Anat Anz 30.
3. Spalteholz W. Die Koronararterien des Herzens. Verhandl Anat Ges. 1907;21:141; in Anat Anz 30.
4. Schaper W, DeBrabander M, Lewi P. DNA-synthesis and mitoses in coronary collateral vessels of the dog. Circ Res. 1971;28: 671-679.
5. Schaper W, Pasyk S. Influence of collateral flow on the ischemic tolerance of the heart following acute and subacute coronary occlusion. Circulation. 1976;53(suppl I):I-57-I-62. Abstract.
6. Schaper W, Schaper J. Collateral Circulation: Heart, Brain, Kidney, Limbs. London, UK: Kluwer Academic Publishers; 1993.
7. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 1992;13:18-42.
8. Klagsbrun M, D'Amore PA. Regulators of angiogenesis. Annu Rev Physiol. 1991;53:217-239.
9. Pepper MS, Montesano R. Proteolytic balance and capillary morphogenesis. Cell Differ Dev. 1990;32:319-327.
10. Sharma HS, Sassen L, Knöll R, Verdouw PD. Myocardial expression of vascular endothelial growth factor: enhanced transcription during ischemia and reperfusion. Circulation. 1992;86 (suppl I):I-1168. Abstract.
11. Connolly D. Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biochem. 1991;47:219-223.
12. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin C-H. Identification of angiogenic activity and the cloning and expression of platelet- derived endothelial cell growth factor. Nature. 1989;338:557-562.
13. Engelmann GL, Dionne CA, Jaye MC. Acidic fibroblast growth factor and heart development: role in myocyte proliferation and capillary angiogenesis. Circ Res, 1993;72:7-19.
14. Leung DW, Cachlanes G, Kuang WJ, Goeddel D, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1990;246:1306-1309.
15. Jakeman LB, Bennett JWGL, Altar CA, Ferrara N. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest. 1992;89:244-253.
16. Peters KG, Vries CD, Williams LT. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci U S A. 1993;90:8915-8919.
17. Millauer B, Wizigmann-Voos S, Schnüreh H, Martinez R, Möller NPH, Risau W, Ullrich A. High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 1993;72:835-846.
18. Shen H, Clauss M, Ryan J, Schmidt A-M, Tijburg P, Borden L, Connolly D, Stern D, Kao J. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood. 1993;81:2767-2773.
19. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan Y-CE, Olander JV, Connolly DT, Stem C. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med. 1990;172:1535-1545.
20. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D. Migration of human monocytes in response to vascular endothe- lial growth-factor (VEGF) is mediated via the VEGF receptor flt-1. Blood. 1996;87:3336-3343.
21. Kluge A, Zimmermann R, Münkel B, Mohri M, Sack S, Schaper J, Schaper W. Insulin-like growth factor I is involved in inflammation linked angiogenic processes after microembolisation in porcine heart. Cardiovasc Res. 1995;29:407-415.
22. Bernotat-Danielowski S, Sharma H, Schott R, Schaper W. Generation and localisation of monoclonal antibodies against fibroblast growth factors in ischaemic collateralised porcine myocardium. Cardiovasc Res. 1993;27:1220-1228.
23. Polverini PJ, Cotran RS, Gimbrone MA, Unanue ER. Activated macrophages induce vascular proliferation. Nature. 1977;269: 804-806.
24. Berse B, Brown LF, Water LVD, Dvorak HF, Dvorak F, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumors. Mol Biol Cell. 1992;3:211-220.
25. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, Sporn MB. Transforming growth factor type ß induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA. 1987;84:5788-5792.
26. Iijima Z, Yoshikawa N, Connolly DT, Nakamura H. Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int. 1993;44:959-966.
27. Goto F, Goto K, Weindel K, Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest. 1993;69:508-517.
28. Rak JW, St Croix BD, Kerbel RS. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anticancer Drugs. 1995;6:3-18.
29. Warren RS, Yuan H, Math MR, Gillett NA, Ferrara N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest. 1995;95:1789-1797.
30. Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Fit in lungs exposed to acute or to chronic hypoxia: modulation of gene expression by nitric oxide. J Clin Invest. 1995;95:1798-1807.
31. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 1992;359:845-848.
32. Westernacher D, Schaper W. A novel heart derived inhibitor of vascular cell proliferation: purification and biological activity. J Mol Cell Cardiol. 1995;27:1535-1543.
33. Rouault JP, Rimokh R, Tessa C, Paranhos G, Ffrench M, Duret L, Garoccio M, Germain D, Samarut J, Magaud JP. BTG1, a member of a new family of antiproliferative genes. EMBO J. 1992;11: 1663-1670.
34. Folkman J. Tumor Angiogenesis. Philadelphia, Pa: WB Saunders Co; 1995.
35. Jackson D, Volpert OV, Bouck N, Linzer DIH. Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein. Science. 1994;266:1581-1584.
36. Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology. 1993;133:1292-1299.
37. Hanneken A, Ying W, Ling N, Baird A. Identification of soluble forms of the fibroblast growth factor receptor in blood. Proc Natl Acad Sci USA. 1994;91:9170-9174.
38. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res. 1994;28:1176-1179.
39. Stavri GR, Hong Y, Zachary IC, Breier GB, Baskerville PA, Ylä- Herttuala S, Risau W, Martin JF, Erusalimsky JD. Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. FEBS Lett. 1995;358:311-315.
40. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843-845.
41. Hashimoto E, Ogita T, Nakaoka T, Matsuoka R, Takao A, Kirka Y. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol. 1994;267:H1948- H1954.
42. Ladoux A, Frelin C. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun. 1993;195:1005-1010.
43. Levy AP, Levy NS, Loscalzo J, Calderone A, Takahashi N, Yeo K-T, Koren D, Colucci WS, Goldberg MA. Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res. 1995;76: 758-766.
44. Fujita M, McKown DP, McKown MD, Franklin D. Changes in coronary flow following repeated brief coronary occlusion in the conscious dog. Heart Vessels. 1986;2:87-90.
45. Ikeda E, Achen MG, Breier G, Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem. 1995; 270:19761-19766.
46. Fischer S, Sharma HS, Karliczek GF, Schaper W. Expression of vascular permeability factor/vascular endothelial growth factor in pig cerebral microvascular endothelial cells and its upregulation by adenosine. Mol Brain Res. 1995;28:141-148.
47. Sparks HV Jr, Bardenheuer H. Regulation of adenosine formation by the heart. Circ Res. 1986;58:193-201.
48. Yang HT, Ogilvie RW, Terjung RL. Peripheral adaptations in trained aged rats with femoral artery stenosis. Circ Res. 1994;74: 235-243.
49. Arras M, Mohri M, Sack S, Schwarz ER, Schaper J, Schaper W. Macrophages accumulate and release tumor necrosis factor-alpha in the ischemic porcine myocardium. Circulation. 1992;86(suppl I): 1-129. Abstract.
50. Leibovich SJ, Ross R. The role of the macrophage in wound repair: a study with hydrocortisone and and macrophage serum. Am J Pathol. 1975;78:71-100.
51. Dumont DJ, Fong G-H, Puri MC, Gradwohl G, Alitalo D, Breitman ML. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dyn. 1995;203:80-92.
52. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol. 1995; 11:73-91.
53. Gorge G, Ito BR, Pantely GA, Schaper W. Effects of chronic coronary artery stenosis on collateral development in swine. J Mol Cell Cardiol. 1986;18(suppl II):11. Abstract.
54. O'Konski MS, White FC, Longhurst JC, Roth D, Bloor CM. Ameroid constriction of the proximal left circumflex coronary artery in swine. Am J Cardiovasc Pathol. 1986;1:69-77.
55. Roth DM, Maruoka Y, Rogers J, White FC, Longhurst JC, Bloor CM. Development of coronary collateral circulation in left circumflex ameroid-occluded swine myocardium. Am J Physiol. 1987; 253:H1279-H1288.
56. White FC, Carroll SM, Magnet A, Bloor CM. Coronary collateral development in swine after coronary artery occlusion. Circ Res. 1992;71:1490-1500.
57. Roth DM, White FC, Bloor CM. Altered minimal coronary resistance to antegrade reflow after chronic coronary artery occlusion in swine, Circ Res. 1988;63:330-339.
58. Schaper J, König R, Franz D, Schaper W. The endothelial surface of growing coronary collateral arteries: intimal margination and diapedesis of monocytes - a combined SEM and TEM study. Virchows Arch A Pathol Anat Histol. 1976;370:193-205.
59. Chilian WM, Mass HJ, Williams SE, Layne SM, Smith ES, Scheel KW. Microvascular occlusions promote coronary collateral growth. Am J Physiol. 1990;258:H1103-H1111.
60. Bloor CM, White FC, Sanders TM. Effects of exercise on collateral development in myocardial ischemia in pigs. J Appl Physiol. 1984; 56:656-665.
61. White FC, Roth DM, Bloor CM. The pig as a model for myocardial ischemia and exercise. Lab Anim Sci. 1986;36:351-356.
62. Roth DM, White FC, Nichols ML, Dobbs SL, Longhurst JC, Bloor CM. Effect of long-term exercise on regional myocardial function and coronary collateral development after gradual coronary artery occlusion in pigs. Circulation. 1990;82:1778-1789.
63. Breisch EA, White FC, Nimmo LA, McKirnan MD, Bloor CM. Exercise-induced cardiac hypertrophy: a correlation of blood flow and microvasculature. J. Appl Physiol. 1986;60:1259-1267.
64. Schaper W. Influence of physical exercise on coronary collateral blood flow in chronic experimental two-vessel occlusion. Circulation. 1982;65:905-912.
65. Pasyk S, Schaper W, Schaper J, Pasyk K, Miskiewicz G, Steinseifer B. DNA synthesis in coronary collaterals after coronary artery occlusion in conscious dog. Am J Physiol. 1982;242:H1031-H1037.
66. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol. 1995;146: 1029-1039.
67. Majano G, Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol. 1995;146:3-15.
68. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol. 1994;124:1-6.
69. Pepper MS, Belin D, Montesano R, Orci L, Vassalli JD. Transforming growth factor beta 1 modulates basic fibroblast growth factor induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol. 1990;111:743-753.
70. Pepper MS, Vassalli JD, Montesano R, Orci L. Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J Cell Biol. 1987;105:2535-2541.
71. Knoepfler PS, Bloor CM, Carroll SM. Urokinase plasminogen activator activity is increased in the myocardium during coronary artery occlusion. J Mol Cell Cardiol. 1995;27:1317-1324.
72. Konkle BA, Ginsburg D. The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression. J Clin Invest. 1988;82:579-585.
73. Saksela O, Moscatelli D, Rifkin B. The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol. 1987;105:957-963.
74. Mandriota SJ, Seghezzi G, Vassalli JD, Ferrara N, Wasi S, Mazzieri R, Mignatti P, Pepper MS. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem. 1995;270:9709-9716.
75. Mignatti P, Tsuboi R, Robbins E, Rifkin DB. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol. 1989;108:571-682.
76. Flaumenhaft R, Abe M, Mignatti P, Rifkin DB. Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: regulation of plasminogen activator activity. J Cell Biol. 1992;118:901-909.
77. Schaper W. Collateral circulation, I: collaterals in chronic coronary occlusion. In: Schaper W, ed. The Pathophysiology of Myocardial Perfusion. Amsterdam, Netherlands: Elsevier/North-Holland Biomedical Press; 1979:415-436.
78. Schaper W. Collateral anatomy and blood flow: its potential role in sudden coronary death. Ann N Y Acad Sci. 1982;382:69-74.
79. Schaper J, Weihrauch D. Collateral vessel development in the porcine and canine heart. In: Schaper W, Schaper J, eds. Collateral Circulation: Heart, Brain, Kidney, Limbs. Dordrecht, Netherlands: Kluwer Academic Publishers; 1993:65-102.
80. Hacking WJG, VanBavel E, Spaan JAE. Shear stress is not sufficient to control growth of vascular networks: a model study. Am J Physiol. 1996;270:H364-H375.
81. Geary RL, Kohler TR, Vergel S, Kirkman TR, Clowes AW. Time course of flow-induced smooth muscle cell proliferation and intimal thickening in endothelialized baboon vascular grafts. Circ Res. 1993;74:14-23.
82. Malek AM, Gibbons GH, Dzau VJ, Izumo S. Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium. J Clin Invest. 1993;92:2013-2021.
83. Mitsumata M, Fishel RS, Nerem RM, Alexander RW, Berk BC. Fluid shear stress stimulates platelet-derived growth factor expression in endothelial cells. Am J Physiol. 1993;150:552-558.
84. Hsieh HJ, Li NQ, Frangos JA. Shear stress increases endothelial platelet-derived growth factor mRNA levels. Am J Physiol. 1991; 260:H642-H646.
85. Hsieh HJ, Li NQ, Frangos JA. Shear-induced platelet-derived growth factor gene expression in human endothelial cells is mediated by protein kinase C. J Cell Physiol. 1992;150:552-558.
86. Thoma R. Untersuchungen über die Histogenese und Histome-chanik des Gefäßsystems. Stuttgart, Germany: F. Enke; 1893.
87. Schaper W. The Collateral Circulation of the Heart. Amsterdam, Netherlands: Elsevier North Holland Publishing Company; 1971.
88. Nagel T, Resnick N, Atkinson W, Dewey WJ, Gimbrone CF. Shear stress upregulates functional ICAM-1 expression in cultured vascular endothelial cells. FASEB J. 1993;7:A2. Abstract.
89. Sampath R, Kukielka GL, Smith CW, Eskin SG, McIntire LV. Shear stress-mediated changes in the expression of leukocyte adhesion receptors on human umbilical vein endothelial cells in vitro. Ann Biomed Eng. 1995;23:247-256.
90. Ando J, Normura H, Kamiya A. The effect of fluid shear stress on the migration and proliferation of cultured endothelial cells. Micro-vascular Res. 1987;33:62-70.
91. Patrick CW, McIntire LV. Shear stress and cyclic strain modulation of gene expression in vascular endothelial cells. Blood Purif. 1995; 13:112-124.
92. +-channel. Circulation. 1992;86(suppl I):I-87. Abstract.
93. Noris M, Morigi M, Conadelli R, Aiello S, Foppolo M, Todeschini M, Orisio S, Remuzzi G, Remuzzi A. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res, 1995;76:536-543.
94. Kourembanas S, Mcquillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest. 1993;92:99-104.
95. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res. 1995;76:980-986.
96. Borgers M, Schaper J, Schaper W. Acute vascular lesions in developing coronary collaterals. Virchows Arch Pathol Anat Physiol Klin Med. 1970;351:1-11.
97. Schaper W, Flameng W, Winkler B, Wuesten B, Türschmann W, Neugebauer G, Carl M, Pasyk S. Quantification of collateral resistance in acute and chronic experimental coronary occlusion in the dog. Circ Res. 1976;39:371-377.
98. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 1994;89:2183-2189.
99. Cuevas P, Gonzalez AM, Carceller F, Baird A. Vascular response to basic fibroblast growth factor when infused onto the normal adventitia or into the injured media of the rat carotid artery. Circ Res. 1991;69:360-369.
100. Kass RW, Kotler MN, Yazdanfar S. Stimulation of coronary collateral growth: current developments in angiogenesis and future clinical applications. Am Heart J. 1991;123:486-496.
101. Leclerc G, Gal D, Takeshita S, Nikol S, Weir L, Isner JM. Percutaneous arterial gene transfer in a rabbit model: efficiency in normal and balloon-dilated atherosclerotic arteries. J Clin Invest. 1992;90: 936-944.
102. Nabel EG, Yang Z-Y, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature. 1993;362:844-846.
103. Nabel EG, Yang Z, Liptay S, San H, Gordon D, Haudenschild CC. Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimal hyperplasia in vivo. J Clin Invest. 1993;91:1822-1829.
104. Harada K, Grossman W, Friedman M, Edelman ER, Prasad PV, Keighley CS, Manning WJ, Sellke FW, Simons M. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest. 1994;94:623-630.
105. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu L-Q, Bunting S, Ferrara N, Symes JF, Isner JM. Therapeutic angiogenesis: a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest. 1994;93:662-670.
106. Unger EF, Banai S, Shou M, Lazarous DF, Jaklitsch MT, Sheinowitz M, Correa R, Klingbeil C, Epstein SE. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol. 1994;266:H1588-H1595.
107. Yanagisawa-Miwa K, Ushida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C, Ito H. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science. 1992;257:1401-1403.
108. Lazarous DF, Scheinowitz M, Shou M, Hodge E, Rajanayagam S, Hunsberger S, Robinson WGJ, Stiber JA, Correa R, Epstein SE. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation. 1995;91:145-153.
109. Baird A, Walicke P. Fibroblast growth factors. Br Med Bull. 1989; 45:438-452.
110. Scheinowitz M, Shou M, Banai S, Gertz SD, Lazarous DF, Unger EF. Neointimal proliferation in canine coronary arteries: a model of restenosis permitting local and continuous drug delivery. Lab Invest. 1994;71:813-819.
111. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am J Physiol. 1994;267:H1263-H1271.